.
MergerLinks Header Logo

Announced

Completed

Novozymes completed the acquisition of PrecisionBiotics Group for $90m.

Financials

Edit Data
Transaction Value£72m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales6x
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Majority

Acquisition

Single Bidder

Completed

Biotechnology

Private

Friendly

probiotics

Ireland

Cross Border

Synopsis

Edit

Novozymes, a global biotechnology company, completed the acquisition of PrecisionBiotics Group, a provider of probiotics for human gut health, for $90m. “By becoming a part of Novozymes, we will get a global presence across businesses and new capabilities within science and discovery of new strains. This will help us to grow by developing new products where we can combine enzymes and probiotics,” Barry Kiely, PrecisionBiotics CEO and Co-Founder.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US